Quadrant Capital Group LLC Dbv Technologies S.A. Transaction History

Quadrant Capital Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$1.22 - $1.77 $239 - $346	-196 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$1.39 - $5.58 $266 - $1,071	-192 Reduced 49.48%	196 $0
Q3 2021 Nov 12, 2021	SELL	$4.71 - $5.92 $7,601 - $9,554	-1,614 Reduced 80.62%	388 $2,000
Q2 2021 Aug 09, 2021	BUY	$5.32 - $6.53 $10,650 - $13,073	2,002 New	2,002 $11,000
Q3 2020 Nov 13, 2020	SELL	$1.58 - $4.77 $464 - $1,402	-294 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.74 - $6.28 $1,099 - $1,846	294 New	294 $1,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.